AMERICAN CENTURY COMPANIES INC - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 315 filers reported holding EDITAS MEDICINE INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$419,702
+48.4%
53,808
+56.6%
0.00%
Q2 2023$282,758
+129.4%
34,357
+96.0%
0.00%
Q1 2023$123,236
-0.9%
17,530
+25.0%
0.00%
Q4 2022$124,384
-96.7%
14,023
-92.9%
0.00%
-100.0%
Q1 2022$3,768,000
-28.4%
198,1100.0%0.00%0.0%
Q4 2021$5,260,000
-35.4%
198,1100.0%0.00%
-50.0%
Q3 2021$8,138,000
-27.4%
198,110
+0.2%
0.01%
-25.0%
Q2 2021$11,202,000
+34.9%
197,7670.0%0.01%
+33.3%
Q1 2021$8,306,000
-46.6%
197,767
-10.9%
0.01%
-50.0%
Q4 2020$15,565,000
+90.9%
222,010
-23.6%
0.01%
+71.4%
Q3 2020$8,153,000
-5.1%
290,5570.0%0.01%
-12.5%
Q2 2020$8,595,000
+26.8%
290,557
-15.0%
0.01%0.0%
Q1 2020$6,780,000
-39.1%
341,889
-9.0%
0.01%
-27.3%
Q4 2019$11,130,000
+30.4%
375,883
+0.1%
0.01%
+22.2%
Q3 2019$8,536,000
-20.8%
375,395
-13.9%
0.01%
-18.2%
Q2 2019$10,783,000
+14.2%
435,833
+12.8%
0.01%
+10.0%
Q1 2019$9,444,000
+19.7%
386,266
+11.4%
0.01%
+11.1%
Q4 2018$7,887,000
+23.4%
346,674
+79.7%
0.01%
+50.0%
Q1 2018$6,394,000
-31.3%
192,873
-36.3%
0.01%
-33.3%
Q4 2017$9,310,000
+24.2%
302,960
-3.0%
0.01%
+12.5%
Q3 2017$7,497,000312,2290.01%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2020
NameSharesValueWeighting ↓
Deep Track Capital, LP 7,101,935$55,395,0932.14%
Green Alpha Advisors, LLC 77,188$602,0660.46%
Woodline Partners LP 3,259,710$25,425,7380.30%
TANG CAPITAL MANAGEMENT LLC 200,000$1,560,0000.22%
Spectrum Planning & Advisory Services Inc. 14,038$109,4960.17%
PDT Partners, LLC 156,515$1,220,8170.15%
CALTON & ASSOCIATES, INC. 13,420$104,6760.15%
Corton Capital Inc. 29,365$229,0470.12%
CAXTON ASSOCIATES LP 61,223$477,5390.07%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 119,287$930,4390.06%
View complete list of EDITAS MEDICINE INC shareholders